Free shipping on all orders over $ 500

MD-222

Cat. No. M21506
MD-222  Structure
Size Price Availability
5mg USD 950  USD950 Custom Synthesis
10mg USD 1650  USD1650 Custom Synthesis
25mg USD 3450  USD3450 Custom Synthesis
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MD-222 is a first-in-class, highly effective ProTAC-based MDM2 depressant. MD-222 has anti-cancer properties.

Chemical Information
Molecular Weight 893.83
Formula C48H47Cl2FN6O6
CAS Number 2136246-72-3
Solubility (25°C) DMSO ≥ 200 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jiuling Yang, et al. J Med Chem. Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders

Related Mdm2 Products
MMRi64

MMRi64 disrupts Mdm2-MdmX interactions.

MeOIstPyrd

MeOIstPyrd is an anti-skin cancer agent.

MDM2/XIAP-IN-3

MDM2/XIAP-IN-3 is a dual MDM2/XIAP inhibitor.

UNP-6457

UNP-6457 is a potent active MDM2-p53 interaction inhibitor with an IC50 values of 8.9 nM.

YL93

YL93 is a dual inhibitors of MDM2/4 with Ki values of 0.64 μM and 1.1 nM for MDM4 and MDM2, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: MD-222 supplier, Mdm2, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.